Rebecca Strawbridge

Dr. Rebecca Strawbridge serves as Senior Lecturer in Affective Disorders at King's College London within the Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience. She is affiliated with the Centre for Affective Disorders and Translational Therapeutics theme of the NIHR Biomedical Research Centre. Her research focuses on mood disorders, biological psychiatry, and cognitive remediation therapy.

Her primary research interests include:

• Mood disorders and treatment-resistant depression
• Inflammatory mechanisms in affective disorders
• Cognitive remediation for bipolar disorder
• Biomarker development for depression and anxiety
• Lithium pharmacology and side effect management

Analysis of her 15 most recent publications reveals strong emphasis on clinical translation of biological findings, particularly inflammatory markers in depression treatment response and cognitive remediation outcomes in bipolar disorder. Her work spans systematic reviews, biomarker studies, and health services research with significant focus on treatment-resistant populations.

Scientific contributions include:

• Development of the Maudsley 3-item Visual Analogue Scale (M3VAS) for depression assessment
• Leadership in the R-LiNK initiative for personalized lithium treatment
• Extensive meta-analyses on augmentation therapies for treatment-resistant depression
• Pioneering research on cognitive remediation mechanisms in bipolar disorder

Her research program demonstrates substantial integration of biological psychiatry with clinical interventions, particularly through examination of inflammatory markers as predictors of treatment response. She maintains active collaborations across European research networks including the Global Bipolar Cohort Collaborative.